| Authors | Patrice Chevallier, Sylvain Chantepie, Francoise Huguet, Emmanuel Raffoux, Xavier Thomas, Thibaut Leguay, Tony Marchand, Francoise Isnard, Aude Charbonnier, Sébastien Maury, Maria-Pilar Gallego-Hernanz, Nelly Robillard, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Fanny Rialland, Claire Le Houerou, David M Goldenberg, William A Wegener, Marie-C Béné, Hervé Dombret |
| Journal | Haematologica
(Haematologica)
Vol. 102
Issue 5
Pg. e184-e186
(05 2017)
ISSN: 1592-8721 [Electronic] Italy |
| PMID | 28154086
(Publication Type: Letter, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antibodies, Monoclonal, Humanized
- Biomarkers
- CD22 protein, human
- Sialic Acid Binding Ig-like Lectin 2
- epratuzumab
- Vincristine
- Dexamethasone
- Doxorubicin
- Cyclophosphamide
|
| Topics |
- Adult
- Antibodies, Monoclonal, Humanized
(administration & dosage)
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Biomarkers
- Cyclophosphamide
(adverse effects, therapeutic use)
- Dexamethasone
(adverse effects, therapeutic use)
- Doxorubicin
(adverse effects, therapeutic use)
- Drug Resistance, Neoplasm
- Female
- Humans
- Male
- Middle Aged
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
(drug therapy, metabolism, mortality, pathology)
- Recurrence
- Retreatment
- Sialic Acid Binding Ig-like Lectin 2
(metabolism)
- Treatment Outcome
- Vincristine
(adverse effects, therapeutic use)
- Young Adult
|
